Postrelapse survival rate correlates with first-line treatment strategy with thalidomide in patients with newly diagnosed multiple myeloma: a meta-analysis

Bortezomib-Cyclophosphamide-Dexamethason

✍ Leiba, Merav; Kedmi, Meirav; Duek, Adrian; Freidman, Tzachi; Weiss, Mia; Leiba, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

Bortezomib-Cyclophosphamide-Dexamethason

✍ Leiba, Merav; Kedmi, Meirav; Duek, Adrian; Freidman, Tzachi; Weiss, Mia; Leiba, 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 521 KB

9235 First-line therapy for patients (pt

✍ Rodríguez, M.L.; Combariza, J.F.; Casas, C.P.; Alarcón, C.; Reveiz, L.; Buendía, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Rates of venous thromboembolism in multi

✍ M. CARRIER; G. LE GAL; J. TAY; C. WU; A. Y. LEE 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 151 KB

Effect of thalidomide with melphalan and

✍ Silvia G. R. Verelst; F. Termorshuizen; C. A. Uyl-de Groot; M. R. Schaafsma; A. 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 274 KB

Consensus guidelines for the optimal man

✍ A. Palumbo; F. Davies; M. Kropff; J. Bladé; M. Delforge; F. Leal da Costa; R. Ga 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 206 KB